etoposide has been researched along with Cancer of Nose in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.70) | 18.2507 |
2000's | 18 (48.65) | 29.6817 |
2010's | 13 (35.14) | 24.3611 |
2020's | 5 (13.51) | 2.80 |
Authors | Studies |
---|---|
Chaturvedi, P; Chaukar, DA; Ghosh Laskar, S; Kumar Singh, A; Menon, N; Noronha, V; Pai, PS; Patil, VM; Patlekar, G; Prabhash, K; Saha, S; Yadav, N | 1 |
Carlos, R; Díaz Molina, JP; Paes de Almeida, O; Sánchez-Romero, C | 1 |
Cong, J; Li, X; Wang, J; Wang, L; Wei, L; Yang, J; Yang, L; Yao, N; Ye, J | 1 |
Bhandari, R; Jat, B; Kumar, P; Sehrawat, A; Singh, A; Sundriyal, D | 1 |
Rais, H; Tazi, I; Tissir, R | 1 |
Bono, W; Bouayad, N; Bouhafa, T; Elmazghi, A; Khalid, H; Masbah, O; Oubelkacem, N | 1 |
Hattori, H; Inagaki, H; Murakami, S; Nakamura, Y; Nakayama, M; Ozaki, S; Suzuki, M; Yokota, M | 1 |
Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC | 1 |
Bae, SH; Chung, J; Heo, DS; Hyun, MS; Jeon, YK; Kang, YK; Kim, BS; Kim, CW; Kim, DW; Kim, H; Kim, HJ; Kim, TM; Lee, JS; Song, HS; Yang, SH; Yuh, YJ | 1 |
Busse, PM; Ebb, DH; Friedmann, AM; Ladra, MM; Lucas, JT; MacDonald, SM; Marcus, KJ; Tarbell, NJ; Yock, TI | 1 |
Antosikova, A; Bosq, J; Carde, P; Chamseddine, AN; Danu, A; Dartigues, P; De Botton, S; Ferme, C; Ghez, D; Girinsky, T; Koscielny, S; Lazarovici, J; Mazeron, R; Michot, JM; Minard, V; Ribrag, V; Willekens, C | 1 |
Ahn, YC; Kim, SJ; Kim, WS; Ko, YH; Oh, D | 1 |
Celentano, A; Cirillo, N; De Rosa, G; Mascolo, M; Mignogna, MD | 1 |
Katayama, N; Miyazaki, K; Monma, F; Nakase, K; Nishii, K; Tawara, I; Ueno, S; Yamaguchi, M | 1 |
Hotta, T; Ishikura, S; Ishizawa, K; Ishizuka, N; Isobe, Y; Itoh, K; Kagami, Y; Kinoshita, T; Kobayashi, Y; Maseki, N; Matsuno, Y; Nawano, S; Oguchi, M; Ohshima, K; Oshimi, K; Terauchi, T; Tobinai, K; Usui, N; Wasada, I; Yamaguchi, M | 1 |
Ahn, YC; Cho, J; Eom, HS; Huh, J; Kang, KM; Kim, BS; Kim, CY; Kim, JS; Kim, K; Kim, SJ; Kim, WS; Ko, YH; Lee, GW; Lee, SW; Pyo, HR; Suh, C | 1 |
Yamaguchi, M | 2 |
Cai, Q; Huang, H; Jiang, W; Lin, X; Lin, Z; Xia, Z | 1 |
Bridger, GP; Broadley, K; Meagher, NS; Smee, RI; Williams, JR | 1 |
Hangaishi, A; Imai, Y; Kobayashi, T; Kurokawa, M; Morikawa, T; Nakamura, F; Ota, S; Shinohara, A; Takazawa, Y; Yamamoto, G | 1 |
Adams, J; Amrein, P; Ancukiewicz, M; Fitzek, MM; Joseph, M; Mcintyre, J; Rosenthal, S; Thornton, AF; Varvares, M | 1 |
Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
Kitanishi, T; Kitano, H; Kouzaki, H; Suzuki, M | 1 |
Hatake, K; Irie, T; Ito, Y; Kamata, S; Kawabata, K; Mishima, Y; Nagasaki, E; Oguchi, M; Takahashi, S; Terui, Y | 1 |
Bang, YJ; Heo, DS; Jo, YH; Kim, DW; Kim, JH; Kim, NK; Kim, TY; Lee, CH; Rhee, CS; Wu, HG | 1 |
Berger, J; Christiansen, H; Hermann, RM; Nitsche, M; Pradier, O | 1 |
Cai, QQ; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, TY; Lin, XB; Pan, ZH; Peng, YL; Xia, YF; Xia, ZJ | 1 |
Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C | 1 |
Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lu, TX; Xia, YF; Xian, CG; Zhang, YJ | 1 |
Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ | 1 |
Buckner, JC; Lewis, JE; McElroy, EA | 1 |
Eisele, DW; Forastiere, A; Lee, DJ; Resto, VA; Westra, WH; Zahurak, M | 1 |
Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
Mineta, H; Miura, K; Tsutsui, Y; Yokota, N | 1 |
5 review(s) available for etoposide and Cancer of Nose
Article | Year |
---|---|
[Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Nasal Mucosa; Neoplasm Staging; Nose Neoplasms; Plasmablastic Lymphoma; Prednisolone; Remission Induction; Tomography, X-Ray Computed; Vincristine | 2020 |
Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Maxillary Sinus Neoplasms; Nasal Obstruction; Nasal Polyps; Nose Neoplasms; Otorhinolaryngologic Surgical Procedures; Papilloma, Inverted; Radiotherapy, Intensity-Modulated | 2019 |
[Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Japan; Killer Cells, Natural; Korea; Lymphoma, T-Cell; Male; Nose Neoplasms; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinical Trials as Topic; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Nose Neoplasms | 2012 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
6 trial(s) available for etoposide and Cancer of Nose
Article | Year |
---|---|
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Killer Cells, Natural; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisolone; Republic of Korea; Treatment Outcome; Young Adult | 2014 |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Japan; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nose Neoplasms; Probability; Proportional Hazards Models; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Risk Assessment; Sex Factors; Survival Analysis; Treatment Outcome; Young Adult | 2009 |
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prospective Studies; Radiotherapy, Adjuvant; Republic of Korea; Risk Assessment; Time Factors; Treatment Outcome; Young Adult | 2009 |
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nausea; Neutropenia; Nose Neoplasms; Prednisone; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine; Vomiting | 2011 |
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Killer Cells, Natural; Leucovorin; Lung Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms; Treatment Outcome | 2003 |
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Etoposide; Female; Humans; Killer Cells, Natural; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Nose Neoplasms; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
26 other study(ies) available for etoposide and Cancer of Nose
Article | Year |
---|---|
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Esthesioneuroblastoma, Olfactory; Etoposide; Humans; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Nose Neoplasms; Paranasal Sinus Neoplasms; Retrospective Studies; Young Adult | 2023 |
Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Chemoradiotherapy; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose; Nose Neoplasms; Skin Neoplasms | 2020 |
SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Vindesine; Young Adult | 2020 |
Facial disfigurement due to olfactory neuroblastoma: beauty regained with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Beauty; Cisplatin; Depression; Diagnosis, Differential; Esthesioneuroblastoma, Olfactory; Etoposide; Face; Female; Humans; Magnetic Resonance Imaging; Nasal Cavity; Nasal Surgical Procedures; Neoadjuvant Therapy; Nose Deformities, Acquired; Nose Neoplasms; Treatment Outcome | 2021 |
[Nasal NK/T-cell lymphoma: about two rare cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nasal Obstruction; Neoplasm Staging; Nose Neoplasms; Prednisolone; Prognosis; Vincristine | 2018 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load | 2014 |
Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Nasal Cavity; Nose Neoplasms; Proton Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Retrospective Studies; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2015 |
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Platinum Compounds; Radiation Dosage; Remission Induction; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2015 |
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Dexamethasone; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome | 2015 |
Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chronic Disease; Delayed Diagnosis; Dexamethasone; Diagnostic Errors; Etoposide; Fistula; Humans; Ifosfamide; Leucovorin; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinusitis; Methotrexate; Mouth Diseases; Nose Diseases; Nose Neoplasms; Palatal Neoplasms; Radiotherapy | 2017 |
[Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Liver Diseases; Lymphoma, Extranodal NK-T-Cell; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Orbital Neoplasms; Radiotherapy Dosage; Remission Induction; Time Factors; Treatment Outcome | 2009 |
Retained role of surgery for olfactory neuroblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Audit; Clinical Protocols; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Male; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Young Adult | 2011 |
Successful treatment of secondary NK/T-cell lymphoma of the testis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Nose Neoplasms; Orchiectomy; Remission Induction; Skin; Testicular Neoplasms; Testis | 2013 |
Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy.
Topics: Adult; Aged; Cisplatin; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Nose Neoplasms; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Radiotherapy, High-Energy; Salvage Therapy | 2002 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell; Male; Mitoxantrone; Nasal Cavity; Nose Neoplasms; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Salvage Therapy; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nose Neoplasms; Retrospective Studies; Vincristine | 2004 |
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Nose Neoplasms; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; General Surgery; Humans; Ifosfamide; Male; Nose Neoplasms; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Teratocarcinoma; Treatment Outcome | 2005 |
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Nose Neoplasms; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 2005 |
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2006 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2006 |
Esthesioneuroblastoma: the Johns Hopkins experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Combined Modality Therapy; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Ganglioneuroma; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Radiotherapy, Adjuvant | 2001 |